DeepMed Research

Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Implementation of IVS3 for Upper Limb Motor Recovery

Not Applicable

Recruiting

Conditions: Neglect, Hemispatial
Mirror Movement
Stroke, Cardiovascular
Motor Activity

Interventions: Device: Intensive Visual Stimulation Device

First Posted Date: 2024-07-03

Last Posted Date: 2024-11-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 25

Registration Number: NCT06483230

Locations: 🇺🇸
Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106, New York, New York, United States

JessieHug Feasibility and Usability Assessment

Not Applicable

Suspended

Conditions: SIDS

Interventions: Device: JessieHug

First Posted Date: 2024-06-20

Last Posted Date: 2024-06-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 50

Registration Number: NCT06466148

Locations: 🇺🇸
NewYork Presbyterian - Weill Cornell Medical Center, New York, New York, United States

E-CEL UVEC Treatment for Anal Fissures

Phase 1

Recruiting

Conditions: Chronic Anal Fissure

Interventions: Biological: E-CEL UVEC cells (AB-207)

First Posted Date: 2024-06-13

Last Posted Date: 2024-08-19

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 12

Registration Number: NCT06456073

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair

Not Applicable

Recruiting

Conditions: Hiatal Hernia

Interventions: Device: Biosynthetic Mesh
Procedure: Hiatal Hernia Repair

First Posted Date: 2024-06-05

Last Posted Date: 2024-12-03

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 200

Registration Number: NCT06444347

Locations: 🇺🇸
Lenox Hill Hospital, New York, New York, United States
🇺🇸
University of Southern California Keck School of Medicine, Los Angeles, California, United States
🇺🇸
Louisiana State University School of Medicine, New Orleans, Louisiana, United States

and more 3 locations

Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study

Early Phase 1

Recruiting

Conditions: Gut Microbiome
Gut Health
Phenylpropionic Acid
Dietary Supplement
L-Phenylalanine

Interventions: Dietary Supplement: L-Phenylalanine 500 mg Veg Capsule product

First Posted Date: 2024-05-29

Last Posted Date: 2025-04-09

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT06433310

Locations: 🇺🇸
Belfer Research Building, New York, New York, United States

Telehealth Group Counseling and Preventive Care for Women

Not Applicable

Recruiting

Conditions: NSTEMI
STEMI
Coronary Artery Disease
ASCVD
Chest Pain
Acute Coronary Syndrome
Myocardial Infarction
Unstable Angina

Interventions: Other: Telehealth Group Counseling

First Posted Date: 2024-05-08

Last Posted Date: 2024-07-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 50

Registration Number: NCT06404515

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

Phase 3

Recruiting

Conditions: Coronary Artery Disease

Interventions: Procedure: Coronary artery bypass grafting (CABG)
Procedure: Percutaneous coronary intervention (PCI)

First Posted Date: 2024-05-06

Last Posted Date: 2024-11-04

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 600

Registration Number: NCT06399692

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Ascension St. Vincent Cardiovascular Research Institute, Carmel, Indiana, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

and more 11 locations

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

Phase 3

Recruiting

Conditions: Coronary Artery Disease

Interventions: Procedure: Coronary artery bypass grafting
Procedure: Percutaneous coronary intervention

First Posted Date: 2024-05-06

Last Posted Date: 2024-11-04

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 600

Registration Number: NCT06399705

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Ascension St. Vincent Cardiovascular Research Institute, Carmel, Indiana, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

and more 11 locations

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Phase 4

Recruiting

Conditions: Meningioma

Interventions: Diagnostic Test: Brain Imaging with [Cu64]DOTATATE
Procedure: Radio-guided Surgery With Neoprobe Utilization

First Posted Date: 2024-04-22

Last Posted Date: 2025-03-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT06377371

Locations: 🇺🇸
New York-Presbyterian/Weill Cornell Medical Center, New York, New York, United States

Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

Phase 2

Recruiting

Conditions: Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Gastric Adenocarcinoma

Interventions: Drug: OBP-301
Drug: Pembrolizumab

First Posted Date: 2024-04-01

Last Posted Date: 2025-05-21

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 27

Registration Number: NCT06340711

Locations: 🇺🇸
Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy